Adam C. Olson, MD

  • Assistant Professor, Radiation Oncology

Adam C. Olson, MD, is a board certified radiation oncologist in the UPMC Department of Radiation Oncology. He treats all pediatric radiation oncology cases and specializes in adult sarcoma, lymphoma, genitourinary, and spine stereotactic radiosurgery.  His clinical interests include the multidisciplinary management of pediatric malignancies as well as adults with sarcomas and genitourinary malignancies.  He is particularly interested in the use of advanced radiation therapy techniques for patients with limited metastatic spread (i.e., oligometastases).

Dr. Olson is a member of the American Society of Clinical Oncology (ASCO), American Society for Radiation Oncology (ASTRO), and the American Brachytherapy Society (ABS).

Teaching Activities

Actively participates in resident and medical student education focusing on best evidence-based practices.

Education & Training

  • Undergraduate: Loyola Marymount University
  • Graduate: University of Pittsburgh School of Medicine, Duke University
  • Residency: Duke University

Representative Publications

  1. Hippocampal dose from stereotactic radiosurgery for 4 to 10 brain metastases: risk factors, feasibility of dose reduction via re-optimization, and patient outcomes. Birer SR,* Olson AC,* Adamson J, Hood R, Susen M, Kim G, Salama JK, Kirkpatrick JP. Med Dosim. 2017 Jul 28. pii: S0958-3947(17)30065-1. * = co-first authors.
  2. Grover S, Gudi S, Gandhi AK, Puri P, Olson A, Rodin D, Balogun O, Dhillon P, Sharma DN, Rath GK, Shrivastava SK, Viswanathan AN, Mahantshetty U. Radiation Oncology in India: Challenges and Opportunities. Semin Radiat Oncol. 2017 Apr;27(2):158-163
  3. Qin R, Olson AC, Singh B, Peterson B, Thomas S, Wolf S, Bhavsar N, Hanks B, Salama JK, Salama AK. Safety and efficacy of radiation in advanced melanoma patients treated with ipilimumab. Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):72-7.
  4. Olson AC, Thomas S, Qin R, Singh B, Salama JK, Kirkpatrick JP, Salama AK. Outcomes and toxicity of stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab. Melanoma Management. 2016 Sep;3(3):177-186.
  5. Olson AC, Coleman CN, Hahm SM, DeWeese TL, Shulman LN, Chabner BA, Chao N, Martei YM, Mundt AJ, Grover S. A Roadmap for a New Academic Pathway for Global Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015 Nov 93(3):493-496.
  6. Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei YM, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM. Training Global Oncologists: Addressing the Global Cancer Control Problem. Front Oncol. 2015 Apr 8;5:80. Pubmed ID 25905040.
  7. Gill BS, Kim H, Houser C, Olson AC*, Kelley J, Edwards RP, Comerci J, Sukumvanich P, Olawaiye AB, Huang M, Courtney-Brooks M, Beriwal S. Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma. Brachytherapy. 2014 Nov-Dec;13(6):542-7. Pubmed ID 25127122.

Research Interest Summary

Optimizing cancer care outcomes through multidisciplinary management

Research Interests

Include combining radiation therapy with systemic therapy agents and utilizing stereotactic body radiation therapy for novel indications.